Search - tctmd.com

Displaying 101 - 120 of 740

Sort: Relevancy | Date

Point/Counterpoint: Provocative Views 2 — TAVR Case Volume Requirements Should Be Increased - Volume Threshold Increases Are Needed to Improve Clinical Outcomes

Presentation TCT 2019

Volume Threshold Increases Are Needed to Improve Clinical Outcomes

Presenter: John Carroll

September 27, 2019

Point/Counterpoint: Provocative Views 1 — Minimalist TAVR Gone Viral - Minimalism? Yes. Rapid Ambulation and Discharge? Yes — But GA and TEE to Optimize Outcomes in Selected Cases

Presentation TCT 2019

Minimalism? Yes. Rapid Ambulation and Discharge? Yes — But GA and TEE to Optimize Outcomes in Selected Cases

Presenter: Philippe Genereux

September 27, 2019

Presentation TCT 2019

Minimalist TAVR for Everyone: Safe, Efficient, and Cost-Effective

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Presenter: Adam Greenbaum

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Presenter: Adnan Chhatriwalla

September 27, 2019

Presentation TCT 2019

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Presenter: Chiu Wong

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

TAVR and Concomitant Atrial Fibrillation: Case Presentation

Presenter: Fabian Nietlispach

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Presenter: Kendra Grubb

September 27, 2019

Presentation TCT 2019

Real-World Experience of the LOTUS Edge Valve

Presenter: Hemal Gada

September 27, 2019

Presentation TCT 2019

TAVR Leriche Lovin’

Presenter: Thomas Waggoner

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

TAVR in the Future: Expanding Technologies, Expanding Indications

Presenter: Christopher Meduri

September 27, 2019

Presentation TCT 2019

ACURATE neo: Features and Benefits for Optimized TAVR

Presenter: Helge Möllmann

September 27, 2019

Presentation TCT 2019

The Pi-Cardia Leaflex Aortic Valve Remodeling System

Presenter: Philippe Genereux

September 27, 2019

Presentation TCT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

Early Experience With a New-Generation Retrograde Transcatheter Aortic Valve System: A Multicenter Registry

Presenter: Mark Hensey

September 27, 2019

Presentation TCT 2019

Prospective Single-Arm Clinical Investigation for the Treatment of Subjects With Severe Symptomatic Aortic Valve Stenosis Using Valvosoft® Pulsed Cavitational Ultrasound Therapy (PCUT): First-in-Man

Presenter: Peter den Heijer, MD

September 27, 2019

Presentation TCT 2019

Optimum Transcatheter Aortic Valve: Global First-in-Human

Presenter: Mathew Williams

September 27, 2019

Advertisement

Volume Threshold Increases Are Needed to Improve Clinical Outcomes

Minimalism? Yes. Rapid Ambulation and Discharge? Yes — But GA and TEE to Optimize Outcomes in Selected Cases

Minimalist TAVR for Everyone: Safe, Efficient, and Cost-Effective

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

TAVR and Concomitant Atrial Fibrillation: Case Presentation

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Real-World Experience of the LOTUS Edge Valve

TAVR Leriche Lovin’

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

TAVR in the Future: Expanding Technologies, Expanding Indications

ACURATE neo: Features and Benefits for Optimized TAVR

The Pi-Cardia Leaflex Aortic Valve Remodeling System

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Early Experience With a New-Generation Retrograde Transcatheter Aortic Valve System: A Multicenter Registry

Prospective Single-Arm Clinical Investigation for the Treatment of Subjects With Severe Symptomatic Aortic Valve Stenosis Using Valvosoft® Pulsed Cavitational Ultrasound Therapy (PCUT): First-in-Man

Optimum Transcatheter Aortic Valve: Global First-in-Human

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content